Amyloid neuropathy mimicking chronic inflammatory demyelinating polyneuropathy

Muscle and Nerve

Volumn 45, Issue 1, 2012, Pages 26-31

  Mathis, Stephane ^a   Magy, Laurent ^b   Diallo, Laho ^b   Boukhris, Sami ^b   Vallat, Jean Michel ^b  

^a UNIVERSITÉ DE POITIERS   (France)

^b LIMOGES UNIVERSITY HOSPITAL   (France)

Author keywords

Amyloid; Cidp; Neuropathy; Primary amyloidosis; Transthyretin

Indexed keywords

AMYLOID; IMMUNOGLOBULIN; PREALBUMIN; PREDNISONE; STEROID;

AGED; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY; CLINICAL ARTICLE; CLINICAL EXAMINATION; CLINICAL FEATURE; ELECTRODIAGNOSIS; ELECTRON MICROSCOPY; FAMILIAL AMYLOID POLYNEUROPATHY; FAMILIAL AMYLOIDOSIS; FEMALE; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOMODULATION; MALE; MOLECULAR GENETICS; NERVE BIOPSY; PRIORITY JOURNAL; SURAL NERVE;

AGED; AGED, 80 AND OVER; AMYLOID NEUROPATHIES; BIOPSY; ELECTROMYOGRAPHY; FEMALE; HUMANS; MALE; METHIONINE; MUTATION; NEURAL CONDUCTION; POLYRADICULONEUROPATHY, CHRONIC INFLAMMATORY DEMYELINATING; PREALBUMIN; SURAL NERVE; VALINE;

EID: 84555195617     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.22229     Document Type: Article

References (25)

1. Rajkumar SV, Gertz MA, Kyle RA. Prognosis of patients with primary systemic amyloidosis who present with dominant neuropathy. Am J Med 1998;104:232-237.
2. Andrade C. A peculiar form of peripheral neuropathy; familiar atypical generalized amyloidosis with special involvement of the peripheral nerves. Brain 1952;75:408-427.
3. Benson MD, Kincaid JC. The molecular biology and clinical features of amyloid neuropathy. Muscle Nerve 2007;36:411-423.
4. Planté-Bordeneuve V, Ferreira A, Lalu T, Zaros C, Lacroix C, Adams D, et al. Diagnostic pitfalls in sporadic transthyretin familial amyloid polyneuropathy (TTR-FAP). Neurology 2007;69:693-698.
5. Conceição I, De Carvalho M. Clinical variability in type I familial amyloid polyneuropathy (Val30Met): comparison between late- and early-onset cases in Portugal. Muscle Nerve 2007;35:116-118.
6. Vucic S, Black K, Chong PST, Cros D. Multifocal motor neuropathy with conduction block: distribution of demyelination and axonal degeneration. Clin Neurophysiol 2007;118:124-130.
7. Adams D. Hereditary and acquired amyloid neuropathies. J Neurol 2001;248:647-657.
8. Adams D, Lozeron P, Theaudin M, Ribrag V, Bourhis JH, Lacroix C. Nouveautés dans le diagnostic et le traitement des neuropathies périphériques liées à l'amylose AL et au syndrome POEMS. Rev Neurol (Paris) 2011;167:57-63.
9. Ando Y, Nakamura M, Araki S. Transthyretin-related familial amyloidotic polyneuropathy. Arch Neurol 2005;62:1057-1062.
10. Planté-Bordeneuve V, Said G. Transthyretin related familial amyloid neuropathy. Curr Opin Neurol 2000;13:569-573.
11. Koike H, Kawagashira Y, Iijima M, Yamamoto M, Hattori N, Tanaka F, et al. Electrophysiological features of late-onset transthyretin Met30 familial amyloid polyneuropathy unrelated to endemic foci. J Neurol 2008;255:1526-1533.
12. Wang AK, Fealey RD, Gehrking TL, Low PA. Patterns of neuropathy and autonomic failure in patients with amyloidosis. Mayo Clin Proc 2008;83:1226-1230.
13. Said G, Planté-Bordeneuve V. Familial amyloid neuropathy: a clinicopathological study. J Neurol Sci 2009;284:149-154.
14. Vallat JM, Magy L, Richard L, Sturtz F, Couratier P. Contribution of electron microscopy to the study of neuropathies associated with an IgG monoclonal paraproteinemia. Micron 2008;39:61-70.
15. Vital C, Vital A, Bouillot-Eimer S, Brechenmacher C, Ferrer X, Lagueny A. Amyloid neuropathy: a retrospective study of 35 peripheral nerve biopsies. J Peripher Nerv Syst 2004;9:232-241.
16. Joint Task Force of the EFNS and the PNS. European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society-First Revision. J Peripher Nerv Syst 2010;15:1-9.
17. Vallat JM, Vital A, Magy L, Martin-Négrier ML, Vital C. An update on nerve biopsy. J Neuropathol Exp Neurol 2009;68:833-844.
18. Vallat JM, Sommer C, Magy L. Chronic inflammatory demyelinating polyradiculoneuropathy: diagnostic and therapeutic challenges for a treatable condition. Lancet Neurol 2010;9:402-412.
19. Cappelen-Smith C, Lin CS, Kuwabara S, Burke D. Conduction block during and after ischaemia in chronic inflammatory demyelinating polyneuropathy. Brain 2002;125:1850-1858.
20. Briemberg HR, Levin K, Amato AA. Multifocal conduction block in peripheral nerve vasculitis. J Clin Neuromuscul Dis 2002;3:153-158.
21. van Asseldonk JTH, van den Berg LH, Wienecke GH, Wokke JHJ, Franssen H. Criteria for conduction block based on computer simulation studies of nerve conduction with human data obtained in the forearm segment of the median nerve. Brain 2006;129:2447-2460.
22. Magy L, Mathis S, Vallat JM. Diagnostic and therapeutic challenges in chronic inflammatory demyelinating polyneuropathy and other immune-mediated neuropathies. Curr Opin Crit Care 2010;17:101-105.
23. Lunn MPT, Willison HJ. Diagnosis and treatment in inflammatory neuropathies. J Neurol Neurosurg Psychiatry 2009;80:249-258.
24. Boukhris S, Magy L, Li Y, Debras C, Vallat JM. Polyradiculonévrite inflammatoire démyélinisante chronique et atteinte du système nerveux autonome. Rev Neurol (Paris) 2005;161:1228-1231.
25. Hellman U, Alarcon F, Lundgren HE, Suhr O, Bonayiti-Pellié C, Planté-Bordeneuve V. Heterogeneity of penetrance in familial amyloid polyneuropathy, ATTR Val30Met, in the Swedish population. Amyloid 2008;15:181-186.